This inventor holds 2 USPTO granted patents. Top assignees: Vanderbilt University, Glaxo Group Limited, King's College London. Active years: 2015-2019.
Location History:
- Franklin, TN (US) (2015)
- Nashville, TN (US) (2019)
Company Filing History:
2 out of 1,220 
1 out of 1,169 
1 out of 196 
Years Active: 2015-2019
Title: C David Weaver: Innovator in Melanocortin Receptor Modulation
Introduction
C David Weaver is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of pharmacology, particularly in the development of modulators for the melanocortin-4 receptor. With a total of 2 patents, his work has implications for various therapeutic applications.
Latest Patents
Weaver's latest patents include innovative discoveries in the realm of receptor modulation. One of his patents focuses on positive allosteric modulators of the human melanocortin-4 receptor. This patent discloses methods of using such modulators to enhance receptor activity. Another significant patent involves small molecule activators of GIRK potassium channels, providing methods for their use in treating various medical conditions.
Career Highlights
Throughout his career, C David Weaver has been associated with prestigious institutions such as Vanderbilt University and King's College London. His work at these institutions has allowed him to explore and develop groundbreaking therapeutic strategies.
Collaborations
Weaver has collaborated with esteemed colleagues, including Roger D Cone and Jaques Pantel. These partnerships have contributed to the advancement of research in receptor modulation and its potential applications.
Conclusion
C David Weaver's contributions to the field of pharmacology through his patents and collaborations highlight his role as an innovator. His work continues to influence the development of new therapeutic strategies.